MAXWELL BIOSYSTEMS AG

MAXWELL BIOSYSTEMS AG specializes in the design and delivery of advanced analytical instrumentation and companion software platforms for life science and environmental research applications. Their core capabilities center on high-density microelectrode array (MEA) systems and consumable-based assay platforms that enable real-time, label-free electrophysiological monitoring of cellular activity. The company integrates proprietary hardware with custom software solutions, including live stimulation and data analysis tools, to support automated, high-throughput screening of biological responses. Technical expertise spans microfabrication, biosensor integration, real-time signal processing, and computational modeling of cellular behavior, with a distinct focus on reproducible, scalable platforms for environmental toxicology and neurobiological research. Differentiators include closed-loop assay systems that combine physical stimulation with dynamic data acquisition, enabling unprecedented precision in cellular response characterization. The contractor maintains a consistent and deep relationship with the Environmental Protection Agency, delivering mission-critical tools for environmental hazard assessment and ecotoxicology studies. Their work supports EPA’s regulatory science initiatives through validated, instrument-based methods for detecting subcellular toxicological effects in vitro, aligning with the agency’s emphasis on non-animal testing alternatives. MAXWELL BIOSYSTEMS operates primarily within NAICS 334516, manufacturing precision analytical instruments for laboratory use, and NAICS 541519, providing specialized computational services for biological data acquisition and simulation. This dual focus positions them at the intersection of biophysics, environmental science, and computational biology, serving government research and regulatory labs requiring validated, instrument-driven analytics. As a Swiss-based entity structured as an 8H, MAXWELL BIOSYSTEMS AG operates without federal certifications but maintains a focused presence in the U.S. government market through direct contract awards to federal scientific agencies. Their geographic footprint is centered in Zurich, with technical delivery and support tailored to U.S. regulatory and research environments.